Publications

2020

Mondello P, Tadros S, Teater M, Fontan L, Chang AY, Jain N, et al. Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma. Cancer Discov. 2020;10(3):440-459.
Youn T, Al'Aref SJ, Narula N, Salvatore S, Pisapia D, Dweck MR, et al. F-Sodium Fluoride Positron Emission Tomography/Computed Tomography in Ex Vivo Human Coronary Arteries With Histological Correlation. Arterioscler Thromb Vasc Biol. 2020;40(2):404-411.
Bander ED, Kocharian G, Liechty B, Tsiouris AJ, Schwartz TH. Spontaneous regression of a clival chordoma. Case report. Acta Neurochir (Wien). 2020;162(2):433-436.
Ghione P, Faruque P, Mehta-Shah N, Seshan V, Ozkaya N, Bhaskar S, et al. T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma. Blood Adv. 2020;4(19):4640-4647.
Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, et al. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. 2020;182(4):1044-1061.e18.
Siddiqui MT. Serous cavity fluids: Momentum, molecules, markers… and more! Cancer Cytopathol. 2020;128(6):381-383.
Herbst RS, Aisner DL, Sonett JR, Turk AT, Weintraub JL, Lindeman NI. Practical Considerations Relating to Routine Clinical Biomarker Testing for Non-small Cell Lung Cancer: Focus on Testing for RET Fusions. Front Med (Lausanne). 2020;7:562480.
Gross MD, Marks LS, Sonn GA, Green DA, Wang GJ, Shoag JE, et al. Reply by Authors. J Urol. 2020;203(3):536.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700